| Literature DB >> 28550639 |
Zhan Su1,2, Fengyu Wu3, Weiyu Hu4, Xiaodan Liu2, Shaoling Wu2, Xianqi Feng2, Zhongguang Cui2, Jie Yang2, Zhenguang Wang3, Hongzai Guan5, Hongguo Zhao2, Wei Wang2, Chunting Zhao6, Jun Peng7.
Abstract
Philadelphia chromosome-positive acute myeloid leukemia is controversial and difficult to distinguish from the blast phase of chronic myeloid leukemia. As a myeloid neoplasm, rare cases of this leukemia manifest multiple soft-tissue tumors or bone lytic lesions. In this paper, we describe a 49-year-old male patient who had an abrupt onset with sharp chest pain, fever, fatigue, emaciation, and splenomegaly. 18F-fluoro-deoxy-glucose positron emission tomography/computed tomography (18F-FDG PET/CT) result showed diffuse and uneven hypermetabolic lesions in the bone marrow with peripheral bone marrow expansion, multiple soft tissue neoplasms with high 18F-FDG uptake, and lytic bone lesions. Bone marrow smear and biopsy detected aberrant blast cells expressing myeloid rather than lymphoid immunophenotype marker. For the existence of Philadelphia chromosome and BCR-ABL1 fusion gene together with complex chromosome abnormalities, a diagnosis of Philadelphia-positive acute myeloid leukemia was made, although the type (de novo or blast crisis) remained unclear.Entities:
Keywords: Philadelphia chromosome; acute myeloid leukemia; mass; osteolysis; positron emission tomography
Mesh:
Substances:
Year: 2017 PMID: 28550639 DOI: 10.1007/s11684-017-0523-x
Source DB: PubMed Journal: Front Med ISSN: 2095-0217 Impact factor: 4.592